Investors considering Sarepta Therapeutics Inc. (SRPT) may find options strategies worthwhile amid a current market price of $20.40 per share. One appealing option is the January 2027 put contract with a $15 strike price, offering a bid of $3.20 per contract. This premium reflects a 21.3% return based on the $15 commitment, translating to a 22.2% annualized rate of return.
Selling this put means investors may end up owning shares only if the contract is exercised—specifically if SRPT shares fall 26.4% or more. If exercised, the effective cost basis would be $11.80 per share after accounting for the premium received. The stock’s twelve-month volatility is recorded at 119%, suggesting that investors should weigh this alongside fundamental analysis before proceeding.
